AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: We further found that overexpression of activated Akt abolished the anti-proliferative and pro-apoptotic effects of propofol (Fig. 3c and d), confirming that propofol acts on CML cells via inhibiting Akt/mTOR pathway.